MY113912A - Method of preventing or treating allergies - Google Patents

Method of preventing or treating allergies

Info

Publication number
MY113912A
MY113912A MYPI96002357A MYPI19962357A MY113912A MY 113912 A MY113912 A MY 113912A MY PI96002357 A MYPI96002357 A MY PI96002357A MY PI19962357 A MYPI19962357 A MY PI19962357A MY 113912 A MY113912 A MY 113912A
Authority
MY
Malaysia
Prior art keywords
methods
cow
preventing
hypersensitivity reactions
milk
Prior art date
Application number
MYPI96002357A
Other languages
English (en)
Inventor
Metsaniitty Leena
Syvaoja Eeva-Liisa
Korhonen Hannu
Isolauri Erika
Salminen Seppo
Original Assignee
Valio Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8543602&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY113912(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Valio Oy filed Critical Valio Oy
Publication of MY113912A publication Critical patent/MY113912A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Dairy Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MYPI96002357A 1995-06-14 1996-06-11 Method of preventing or treating allergies MY113912A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI952926A FI104465B (fi) 1995-06-14 1995-06-14 Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö

Publications (1)

Publication Number Publication Date
MY113912A true MY113912A (en) 2002-06-29

Family

ID=8543602

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI96002357A MY113912A (en) 1995-06-14 1996-06-11 Method of preventing or treating allergies

Country Status (26)

Country Link
US (2) US6506380B1 (enExample)
EP (1) EP0833649B2 (enExample)
JP (1) JP3983804B2 (enExample)
KR (1) KR100494741B1 (enExample)
CN (1) CN1154506C (enExample)
AR (1) AR003960A1 (enExample)
AT (1) ATE230606T1 (enExample)
BG (1) BG63153B1 (enExample)
BR (1) BR9607827A (enExample)
CA (1) CA2224320C (enExample)
CZ (1) CZ291904B6 (enExample)
DE (1) DE69625690T3 (enExample)
DK (1) DK0833649T4 (enExample)
EE (1) EE03424B1 (enExample)
ES (1) ES2191103T5 (enExample)
FI (1) FI104465B (enExample)
IL (1) IL122577A0 (enExample)
MX (1) MX9710109A (enExample)
MY (1) MY113912A (enExample)
NO (1) NO321504B1 (enExample)
NZ (1) NZ310478A (enExample)
PL (1) PL185123B1 (enExample)
RO (1) RO120243B1 (enExample)
SK (1) SK284245B6 (enExample)
WO (1) WO1997000078A1 (enExample)
ZA (1) ZA965088B (enExample)

Families Citing this family (166)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
AU750136B2 (en) * 1997-06-03 2002-07-11 Ganeden Biotech, Inc. Probiotic lactic acid bacterium to treat bacterial infections associated with SIDS
JP2002534966A (ja) 1999-01-19 2002-10-22 マキシジェン， インコーポレイテッド オリゴヌクレオチド媒介核酸組換え
EP1206523B1 (en) 1999-08-05 2009-03-11 Société des Produits Nestlé S.A. Bifidobacteria preventing diarrhea caused by pathogenic bacteria
US6998119B1 (en) 1999-08-05 2006-02-14 Nestec S.A. Feed composition containing Bifidobacterium CNCM 1-2168 capable of preventing diarrhea
AU2001234784A1 (en) * 2000-02-04 2001-08-14 Bioseek Compositions and methods for reducing autoimmunity
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
EP1379635A2 (en) * 2000-09-25 2004-01-14 Societe Des Produits Nestle S.A. Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
CN100553646C (zh) * 2000-10-06 2009-10-28 雀巢产品股份有限公司 用乳酸菌微生态制剂调节皮肤免疫系统
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
EP1228707A1 (en) * 2001-02-01 2002-08-07 Campina Melkunie B.V. Use of alpha-lactalbumin as prebiotic agent
JP2004519241A (ja) * 2001-03-09 2004-07-02 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム 高齢化に伴う生理的障害を改善し寿命を延ばす組成物
JP2003137804A (ja) * 2001-10-31 2003-05-14 Morinaga Milk Ind Co Ltd インターロイキン−１８誘導剤
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
WO2003102195A1 (en) 2002-06-04 2003-12-11 Dsm Ip Assets B.V. Protein hydrolysate rich in tripeptides
DK1565547T4 (da) 2002-06-28 2013-01-14 Biosearch S A Probiotiske stammer, en fremgangsmåde til selektion deraf, præparater deraf samt anvendelse deraf
EP1384483A1 (en) 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
PT1638416E (pt) * 2003-06-23 2013-07-08 Nestec Sa Utilização de uma fórmula nutricional para função de barreira intestinal óptima
ES2552053T3 (es) 2004-02-25 2015-11-25 Pioneer Hi-Bred International Inc. Nuevos polipéptidos cristalinos de Bacillus thuringiensis, polinucleótidos, y composiciones de los mismos
US20050265946A1 (en) * 2004-05-28 2005-12-01 Kao Corporation Elastase inhibitor
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
EP2108269A1 (en) 2005-04-13 2009-10-14 Nestec S.A. Infant formula with low dose probiotics and low dose proteins
US7303745B2 (en) 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
EP1951064B2 (en) * 2005-11-14 2020-05-13 Société des Produits Nestlé S.A. Oral tolerance promotion with glycated proteins
ES2381211T3 (es) 2006-02-15 2012-05-24 Nestec S.A. Uso del Bifidobacterium longum para prevenir y tratar inflamaciones
ES2553636T3 (es) 2006-03-07 2015-12-10 Nestec S.A. Mezcla simbiótica
CA2653157A1 (en) * 2006-06-15 2007-12-21 Nestec S.A. Induction of tolerance to egg proteins
CN105796607A (zh) * 2007-02-28 2016-07-27 Mjn 美国控股有限责任公司 用于儿童或婴幼儿的含有灭活益生菌的产品
EP1974735A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
CN101273737B (zh) * 2007-03-28 2011-08-24 哈尔滨正方科技有限公司 一种在常温下保持高活菌数的发酵乳饮料的制备方法
EP1974734A1 (en) † 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
EP1974743A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
CN101784669B (zh) 2007-08-24 2015-02-18 科德克希思公司 用于(r)-3-羟基四氢噻吩的立体选择性制备的改善的酮还原酶多肽
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
WO2009092628A1 (en) 2008-01-24 2009-07-30 Nestec S.A. Capsule containing nutritional ingredients and method of delivery of a nutritional liquid from the capsule
ES2950396T3 (es) 2008-02-01 2023-10-09 Prota Therapeutics Pty Ltd Un método para inducir tolerancia a un alérgeno
EP2265135B1 (en) 2008-03-14 2017-12-20 Nestec S.A. Synbiotic mixture
EP2127661A1 (en) 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
HUE029228T2 (en) 2008-06-13 2017-02-28 Codexis Inc A method for the synthesis of polynucleotide variants
JP2011525533A (ja) 2008-06-24 2011-09-22 コデクシス， インコーポレイテッド 実質的に立体異性的に純粋な縮合二環式プロリン化合物の調製のための生体触媒法
EP2147678A1 (en) 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
RU2392001C2 (ru) * 2008-08-04 2010-06-20 Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" Способ лечения желтушных форм вирусного гепатита а у детей с пищевой аллергией
SI2329013T1 (sl) 2008-08-27 2016-03-31 Codexis, Inc. Polipeptidi ketoreduktaze za proizvodnjo 3-aril-3-hidroksipropanamina iz 3-aril-3-ketopropanamina
US8470564B2 (en) 2009-01-08 2013-06-25 Codexis, Inc. Transaminase polypeptides
BRPI1013886A2 (pt) 2009-03-17 2016-10-11 Codexis Inc variantes de endoglucanases, polinucleotídeos e usos a elas relacionados
BRPI1010239A2 (pt) 2009-03-31 2016-10-11 Codexis Inc endoglucanases aprimoradas, derivados e seus usos
EP2443139B1 (en) 2009-06-16 2016-08-10 Codexis, Inc. Beta-glucosidase variant enzymes and related polynucleotides
EP2446025B1 (en) 2009-06-22 2018-08-08 Codexis, Inc. Ketoreductase-mediated stereoselective route to alpha chloroalcohols
WO2011011630A2 (en) 2009-07-23 2011-01-27 Codexis, Inc. Nitrilase biocatalysts
ES2518490T3 (es) * 2009-08-18 2014-11-05 Nestec S.A. Una composición nutritiva, la cual comprende cepas de Lactococcus y que reduce los síntomas de alergia, especialmente, en lactantes y en niños
AU2010285128B2 (en) * 2009-08-18 2015-05-14 Société des Produits Nestlé S.A. A nutritional composition comprising Bifidobacterium longum strains and reducing food allergy symtoms, especially in infants and children
WO2011022548A2 (en) 2009-08-19 2011-02-24 Codexis, Inc. Ketoreductase polypeptides for the preparation of phenylephrine
CA2772859C (en) 2009-09-04 2015-05-26 Codexis, Inc. Variant cbh2 cellulases and related polynucleotides
EP2295535A1 (en) * 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
SG179197A1 (en) 2009-09-18 2012-04-27 Codexis Inc Reduced codon mutagenesis
BR112012012192A2 (pt) 2009-11-25 2017-07-04 Codexis Inc b-glicosidades variantes recombinantes thermoascus aurantiacus para produção de açúcares fermentáveis a partir da biomassa celulósica
EP2706119B1 (en) 2009-11-25 2015-08-12 Codexis, Inc. Recombinant beta-glucosidase variants for production of soluble sugars from cellulosic biomass
EP2510089B1 (en) 2009-12-08 2015-10-21 Codexis, Inc. Synthesis of prazole compounds
US9226521B2 (en) 2009-12-08 2016-01-05 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
CA2786001A1 (en) 2009-12-31 2011-07-07 Pioneer Hi-Bred International, Inc. Engineering plant resistance to diseases caused by pathogens
US9040262B2 (en) 2010-05-04 2015-05-26 Codexis, Inc. Biocatalysts for ezetimibe synthesis
JP2013528374A (ja) 2010-05-10 2013-07-11 パーシード セラピューティクス リミテッド ライアビリティ カンパニー Ｖｌａ４のポリペプチド阻害剤
EP2576804B1 (en) 2010-05-28 2016-12-14 Codexis, Inc. Pentose fermentation by a recombinant microorganism
WO2011159910A2 (en) 2010-06-17 2011-12-22 Codexis, Inc. Biocatalysts and methods for the synthesis of (s)-3-(1-aminoethyl)-phenol
CA2804019A1 (en) 2010-06-28 2012-01-12 Codexis, Inc. Fatty alcohol forming acyl reductases (fars) and methods of use thereof
WO2012003299A2 (en) 2010-06-30 2012-01-05 Codexis, Inc. Highly stable beta-class carbonic anhydrases useful in carbon capture systems
CA2808098C (en) 2010-08-16 2020-03-10 Merck Sharp & Dohme Corp. Process for preparing aminocyclohexyl ether compounds
EP2606131B1 (en) 2010-08-20 2017-03-08 Codexis, Inc. Use of glycoside hydrolase 61 family proteins in processing of cellulose
HUE037616T2 (hu) 2010-12-08 2018-09-28 Codexis Inc Biokatalizátorok és eljárások armodafinil szintéziséhez
EE05750B1 (et) 2011-02-25 2015-06-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine
WO2012135110A1 (en) 2011-03-30 2012-10-04 Codexis, Inc. Pentose fermentation by a recombinant microorganism
DK2697662T3 (en) 2011-04-13 2018-07-30 Codexis Inc BIOCATALYTIC PROCEDURE FOR PREPARING ESLICARBAZEPIN AND ANALOGUES THEREOF
UA111078C2 (uk) * 2011-05-03 2016-03-25 Нестек С.А. Гідролізат білкового субстрату і спосіб його виготовлення
WO2013003219A1 (en) 2011-06-30 2013-01-03 Codexis, Inc. Pentose fermentation by a recombinant microorganism
BR112014004171A2 (pt) 2011-08-22 2018-11-06 Codexis Inc variantes da proteína glicósideo hidrolase gh61 e cofatores que aumentam a atividade de gh61
CN103998461B (zh) 2011-09-08 2018-02-02 科德克希思公司 用于合成取代的内酰胺的生物催化剂和方法
BR112014007719A2 (pt) 2011-09-30 2017-06-13 Codexis Inc proteases fúngicas
US20130084271A1 (en) * 2011-10-03 2013-04-04 Kelly Foods Corporation Probiotic composition for pets and method of providing the same
US20130089638A1 (en) * 2011-10-11 2013-04-11 Mead Johnson Nutrition Company Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes
CN104053771B (zh) 2011-11-18 2016-11-09 科德克希思公司 用于制备羟基取代的氨基甲酸酯的生物催化剂
US9611462B2 (en) 2011-12-20 2017-04-04 Codexis, Inc. Endoglucanase 1B (EG1B) variants
WO2013142770A1 (en) 2012-03-23 2013-09-26 Codexis, Inc. Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
DK2847327T3 (en) 2012-05-08 2019-03-11 Codexis Inc BIO-CATALYSTS AND METHODS FOR HYDROXYLATION OF CHEMICAL COMPOUNDS
US9193957B2 (en) 2012-05-11 2015-11-24 Codexis, Inc. Engineered imine reductases and methods for the reductive animation of ketone and amine compounds
WO2013188305A2 (en) 2012-06-11 2013-12-19 Codexis, Inc. Fungal beta-xylosidase variants
WO2014081605A1 (en) 2012-11-20 2014-05-30 Codexis, Inc. Pentose fermentation by a recombinant microorganism
EP3406594A1 (en) 2012-12-07 2018-11-28 Merck Sharp & Dohme Corp. Biocatalytic transamination process
CN105008528A (zh) 2012-12-21 2015-10-28 科德克希思公司 用于合成手性胺的工程化的生物催化剂和方法
US9540622B2 (en) 2013-01-18 2017-01-10 Codexis, Inc. Engineered biocatalysts useful for carbapenem synthesis
SI2961844T1 (sl) 2013-02-28 2018-11-30 Codexis, Inc. Spremenjeni polipeptidi transaminaze za industrijsko biokatalizo
CN103355405A (zh) * 2013-04-07 2013-10-23 苏州旭优食品科技有限公司 一种低过敏性含乳制品的加工工艺
SG11201508598YA (en) 2013-04-18 2015-11-27 Codexis Inc Engineered phenylalanine ammonia lyase polypeptides
HUE053379T2 (hu) 2013-11-13 2021-06-28 Codexis Inc Génmódosított imin-reduktázok és eljárások keton és amin vegyületek reduktív aminálására
DK3145536T3 (da) 2014-04-16 2022-01-03 Codexis Inc Modificeret tyrosinammoniaklyase
EP3167052B1 (en) 2014-07-09 2020-01-01 Codexis, Inc. P450-bm3 variants with improved activity
CA2968275C (en) 2014-11-25 2023-09-12 Codexis, Inc. Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
KR102438885B1 (ko) 2014-12-22 2022-09-01 코덱시스, 인코포레이티드 인간 알파-갈락토시다제 변이체
US10696953B2 (en) 2015-02-10 2020-06-30 Codexis, Inc. Ketoreductase polypeptides for the synthesis of chiral compounds
EP3292136B1 (en) 2015-05-07 2021-02-17 Codexis, Inc. Penicillin-g acylases
CN108271374B (zh) 2015-07-07 2021-09-21 科德克希思公司 具有改进的活性的新颖p450-bm3变体
US10724025B2 (en) 2016-05-05 2020-07-28 Codexis, Inc. Penicillin-G acylases
WO2017213758A1 (en) 2016-06-09 2017-12-14 Codexis, Inc. Biocatalysts and methods for hydroxylation of chemical compounds
SG11201810998WA (en) 2016-06-15 2019-01-30 Codexis Inc Engineered beta-glucosidases and glucosylation methods
EP4223766A3 (en) 2016-08-26 2023-10-18 Codexis, Inc. Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
KR102696584B1 (ko) 2017-01-05 2024-08-19 코덱시스, 인코포레이티드 페니실린 ｇ 아실라아제
IL321402A (en) 2017-02-03 2025-08-01 Tate & Lyle Solutions Usa Llc Engineered glycosyltransferases and steviol glycoside glucosylation methods
NZ755628A (en) 2017-02-13 2023-09-29 Codexis Inc Engineered phenylalanine ammonia lyase polypeptides
MA48475A (fr) 2017-04-24 2020-03-04 Tesaro Inc Procédés de fabrication de niraparib
CA3061133A1 (en) 2017-04-27 2018-11-01 Codexis, Inc. Ketoreductase polypeptides and polynucleotides
EP3635101B1 (en) 2017-05-08 2021-08-18 Codexis, Inc. Engineered ligase variants
CN111032682B (zh) 2017-06-14 2024-04-12 科德克希思公司 用于工业生物催化的工程化转氨酶多肽
EP3645713A4 (en) 2017-06-27 2021-06-30 Codexis, Inc. PENICILLIN-G ACYLASES
US10793841B2 (en) 2017-06-30 2020-10-06 Codexis, Inc. T7 RNA polymerase variants
JP2020530267A (ja) 2017-06-30 2020-10-22 コデクシス， インコーポレイテッド Ｔ７ ｒｎａポリメラーゼバリアント
CA3080512A1 (en) 2017-11-07 2019-05-16 Codexis, Inc. Transglutaminase variants
WO2019116311A1 (en) 2017-12-13 2019-06-20 Glaxosmithkline Intellectual Property Development Limited Carboxyesterase biocatalysts
SG11202004185PA (en) 2017-12-13 2020-06-29 Codexis Inc Carboxyesterase polypeptides for amide coupling
US10900055B2 (en) 2018-06-12 2021-01-26 Codexis, Inc. Engineered tyrosine ammonia lyase
MX2021000328A (es) 2018-07-09 2021-03-25 Codexis Inc Enzimas de variantes de galactosa oxidasa modificadas geneticamente.
KR20210032417A (ko) 2018-07-09 2021-03-24 코덱시스, 인코포레이티드 조작된 데옥시리보스-포스페이트 알돌라아제
CA3103819A1 (en) 2018-07-09 2020-01-16 Codexis, Inc. Engineered pantothenate kinase variant enzymes
EP3821026A4 (en) 2018-07-09 2022-06-01 Codexis, Inc. MANIPULATED ENZYME VARIANTS OF PHOSPHOPENTOMUTASE
US11162105B2 (en) 2018-07-09 2021-11-02 Codexis, Inc. Engineered purine nucleoside phosphorylase variant enzymes
CA3105916A1 (en) 2018-07-12 2020-01-16 Codexis, Inc. Engineered phenylalanine ammonia lyase polypeptides
MX2021001260A (es) 2018-07-30 2021-04-12 Tate & Lyle Solutions Usa Llc Glucosiltransferasas modificadas con ingenieria genetica y metodos de glucosilacion de glucosido de esteviol.
EP3874033A4 (en) 2018-10-29 2022-08-03 Codexis, Inc. ENGINEERED DNA POLYMERASE VARIANTS
US11473077B2 (en) 2018-12-14 2022-10-18 Codexis, Inc. Engineered tyrosine ammonia lyase
CN113544268A (zh) 2018-12-20 2021-10-22 科德克希思公司 人类α半乳糖苷酶变体
SG11202110852RA (en) 2019-05-01 2021-10-28 Codexis Inc Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
US12215359B2 (en) 2019-05-01 2025-02-04 Codexis, Inc. Engineered glucose dehydrogenases and methods for the reductive amination of ketone and amine compounds
US12275962B2 (en) 2019-07-02 2025-04-15 Codexis, Inc. Engineered acetate kinase variant enzymes
KR20220028053A (ko) 2019-07-02 2022-03-08 코덱시스, 인코포레이티드 조작된 수크로스 포스포릴라제 변이체 효소
ES2983662T3 (es) 2019-07-23 2024-10-24 Frieslandcampina Nederland Bv Composición nutricional que comprende grasa láctea e inmunoglobulina
US11987823B2 (en) 2019-08-30 2024-05-21 Societe Des Produits Nestle S.A. Engineered lipase variants
CA3149870A1 (en) 2019-09-12 2021-03-18 Codexis, Inc. Peroxidase activity towards 10-acetyl-3,7-dihydroxyphenoxazine
AU2020358714A1 (en) 2019-10-02 2022-05-12 Abbott Diabetes Care Inc. Detection of analytes by protein switches
WO2021108209A1 (en) 2019-11-26 2021-06-03 Codexis, Inc. Biocatalysts and methods for hydroxylation of chemical compounds
WO2021127457A1 (en) 2019-12-20 2021-06-24 Codexis, Inc. Engineered acid alpha-glucosidase variants
CA3168922A1 (en) 2020-02-04 2021-08-12 Codexis, Inc. Engineered leucine decarboxylases
CA3179751A1 (en) 2020-04-10 2021-10-14 Codexis, Inc. Engineered transaminase polypeptides
JP2023539632A (ja) 2020-08-28 2023-09-15 コデクシス， インコーポレイテッド 操作されたプロテアーゼバリアント
MX2023002421A (es) 2020-08-28 2023-05-18 Codexis Inc Variantes de amilasa modificadas geneticamente.
EP4259772A1 (en) 2020-12-11 2023-10-18 Willow Biosciences, Inc. Recombinant acyl activating enzyme (aae) genes for enhanced biosynthesis of cannabinoids and cannabinoid precursors
EP4262804A4 (en) 2020-12-18 2025-02-12 Codexis, Inc. Engineered uridine phosphorylase variant enzymes
CA3214973A1 (en) 2021-04-02 2022-10-06 Codexis, Inc. Engineered guanylate kinase variant enzymes
IL305924B2 (en) 2021-04-02 2025-09-01 Codexis Inc Engineered Cyclic GMP-AMP Synthase (CGAS) Variant Enzymes
US11913037B2 (en) 2021-04-02 2024-02-27 Codexis, Inc. Engineered adenylate kinase variant enzymes
CA3215105A1 (en) 2021-04-02 2022-10-06 Codexis, Inc. Engineered acetate kinase variant enzymes
AU2022279241A1 (en) 2021-05-21 2023-11-30 Codexis, Inc. Engineered methionine gamma lyase variants
EP4377451A2 (en) 2021-07-30 2024-06-05 Willow Biosciences, Inc. Recombinant prenyltransferase polypeptides engineered for enhanced biosynthesis of cannabinoids
WO2023023621A1 (en) 2021-08-19 2023-02-23 Willow Biosciences, Inc. Recombinant olivetolic acid cyclase polypeptides engineered for enhanced biosynthesis of cannabinoids
WO2023064938A1 (en) 2021-10-15 2023-04-20 Codexis, Inc. Engineered dna polymerase variants
WO2023069921A1 (en) 2021-10-19 2023-04-27 Epimeron Usa, Inc. Recombinant thca synthase polypeptides engineered for enhanced biosynthesis of cannabinoids
DE112023000593T5 (de) 2022-03-31 2024-11-14 Qingdao Kingagroot Chemical Compound Co., Ltd. Monoaminoxidase und deren anwendung
WO2024040020A1 (en) 2022-08-15 2024-02-22 Absci Corporation Quantitative affinity activity specific cell enrichment
CN120981566A (zh) 2023-01-12 2025-11-18 诺华股份有限公司 工程化酮还原酶多肽
WO2025061911A1 (en) 2023-09-22 2025-03-27 Glaxosmithkline Intellectual Property Development Limited Methods of producing nucleotide triphosphates (ntps)
WO2025144700A1 (en) 2023-12-27 2025-07-03 Absci Corporation Nanobody library screening using bacterial surface display
WO2025235589A1 (en) 2024-05-08 2025-11-13 Codexis, Inc. Dna polymerase variants
WO2025242702A1 (en) 2024-05-23 2025-11-27 Glaxosmithkline Intellectual Property Development Limited Enzymatic process for producing n-acetyl galactosamine clusters

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886288A (en) * 1970-06-15 1975-05-27 Swift & Co Cheese manufacture using highly active proteolytic enzymes
JPS5279086A (en) 1975-12-25 1977-07-02 Nippon Soda Co Ltd Preparation of antibiotic tunicamycin
JPS5279083A (en) * 1975-12-26 1977-07-02 Morinaga Milk Industry Co Ltd Production of protein decomposed substance not having bitterness and antigen property
JPS6041751B2 (ja) 1976-06-22 1985-09-18 ジエコ−株式会社 デジタル電子時計
JPS548785A (en) 1977-06-21 1979-01-23 Kikkoman Corp Preparation of protein hydrolyzate
US4839281A (en) † 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
DK589785A (da) * 1985-12-18 1987-06-19 Samuelsson Ernst Gunnar Peptidpraeparat, fremgangsmaade til fremstilling deraf samt anvendelse af peptidpraeparatet
ATE84680T1 (de) † 1987-12-23 1993-02-15 Nestle Sa Verfahren zur herstellung eines molkeeiweisshydrolysates und eines hypoallergenen nahrungsmittels.
DD281540A5 (de) * 1988-08-08 1990-08-15 Berlin Chemie Veb Verfahren zur herstellung von nutritiva
ES2063882T5 (es) † 1989-10-02 2001-12-01 Novartis Nutrition Ag Hidrolizados de proteinas.
JP3071877B2 (ja) † 1991-06-27 2000-07-31 財団法人糧食研究会 経口寛容誘導能を有する低アレルゲン性酵素分解ペプチド組成物
US5952034A (en) * 1991-10-12 1999-09-14 The Regents Of The University Of California Increasing the digestibility of food proteins by thioredoxin reduction
EP0577903B1 (fr) * 1992-07-06 1997-12-17 Societe Des Produits Nestle S.A. Agent antigastrite
FI94089C (fi) 1992-12-10 1995-07-25 Valio Oy Menetelmä allergiaa aiheuttavien yhdisteiden poistamiseksi proteiinipitoisista koostumuksista
RU2031586C1 (ru) 1993-02-05 1995-03-27 Тамара Георгиевна Извекова Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения
GB9312369D0 (en) 1993-06-16 1993-07-28 Sandoz Nutrition Ltd Organic compounds
AU1076595A (en) † 1993-11-23 1995-06-13 Kabushiki Kaisha Wado Doctors Group Intestinal flora improver composition, and apparatus and system for producing the same
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö

Also Published As

Publication number Publication date
NO321504B1 (no) 2006-05-15
SK284245B6 (sk) 2004-12-01
DE69625690T2 (de) 2003-11-06
AU710126B2 (en) 1999-09-16
NO975832D0 (no) 1997-12-11
WO1997000078A1 (en) 1997-01-03
JPH11510791A (ja) 1999-09-21
US7172756B2 (en) 2007-02-06
ES2191103T3 (es) 2003-09-01
PL324010A1 (en) 1998-04-27
US20030113340A1 (en) 2003-06-19
BG102144A (en) 1998-12-30
PL185123B1 (pl) 2003-02-28
CA2224320C (en) 2012-03-20
DK0833649T3 (da) 2003-04-07
FI952926L (fi) 1996-12-15
ATE230606T1 (de) 2003-01-15
CA2224320A1 (en) 1997-01-03
MX9710109A (es) 1998-10-31
FI104465B (fi) 2000-02-15
RO120243B1 (ro) 2005-11-30
SK171597A3 (en) 1998-11-04
BG63153B1 (bg) 2001-05-31
US6506380B1 (en) 2003-01-14
CN1187772A (zh) 1998-07-15
CZ291904B6 (cs) 2003-06-18
KR19990022914A (ko) 1999-03-25
KR100494741B1 (ko) 2005-09-30
CZ399797A3 (cs) 1998-06-17
ES2191103T5 (es) 2009-11-03
DK0833649T4 (da) 2009-07-20
EP0833649A1 (en) 1998-04-08
JP3983804B2 (ja) 2007-09-26
BR9607827A (pt) 1999-11-30
EP0833649B1 (en) 2003-01-08
NZ310478A (en) 2000-01-28
IL122577A0 (en) 1998-06-15
AR003960A1 (es) 1998-09-30
EE03424B1 (et) 2001-06-15
HK1010081A1 (en) 1999-06-11
FI952926A0 (fi) 1995-06-14
AU6127896A (en) 1997-01-15
DE69625690T3 (de) 2009-12-24
EE9700339A (et) 1998-06-15
NO975832L (no) 1997-12-11
CN1154506C (zh) 2004-06-23
EP0833649B2 (en) 2009-06-03
DE69625690D1 (de) 2003-02-13
ZA965088B (en) 1997-01-22

Similar Documents

Publication Publication Date Title
MY113912A (en) Method of preventing or treating allergies
Kirjavainen et al. New aspects of probiotics–a novel approach in the management of food allergy.
Rosa et al. Milk kefir: nutritional, microbiological and health benefits
Goldin Health benefits of probiotics
Batiha et al. Dairy-derived and egg white proteins in enhancing immune system against COVID-19
Gorbach Probiotics and gastrointestinal health
RU2603059C2 (ru) Изолированные штаммы микроорганизмов lactobacillus plantarum mcc1 dsm 23881 и lactobacillus gasseri mcc2 dsm 23882 и их применение
Nagao et al. Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects
TW445136B (en) Anti-stress agent and functional food having anti-stress effect
US5744134A (en) Immunoglobulin and fiber-containing composition for human gastrointestinal health
US20180037637A1 (en) PROBIOTICS, SECRETORY IgA AND INFLAMMATION
Miciński et al. Characteristics of cow's milk proteins including allergenic properties and methods for its reduction
PL366049A1 (en) Nutritional composition
HU225485B1 (en) Enteral dietary compositions comprising streptococcus thermophilus and bifidobacterium longum
WO2004039315A2 (en) Method for treating wounds to promote healing
Cano et al. Immunological effects of yogurt addition to a re-nutrition diet in a malnutrition experimental model
US20090196867A1 (en) Soy kefir powder and uses thereof
US20090221469A1 (en) Use of soy kefir powder for reducing pain, blood pressure and inflammation
RU2196432C1 (ru) Композиция для приготовления кисломолочного продукта геродиетического питания
Brunser et al. Functional fermented milk products
CN101190279A (zh) 一种健胃、止泻中药饮料
Van de Water Yogurt and immunity: the health benefits of fermented milk products that contain lactic acid bacteria
RU98100444A (ru) Способы профилактики или лечения аллергии
JP4010062B2 (ja) アトピー性皮膚炎を防ぐ保健食品
RU92001155A (ru) Способ получения ферментированного продукта из пахты